Navigation Links
Danaher to Present at Robert W. Baird Industrial Conference
Date:11/4/2008

WASHINGTON, Nov. 4 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas will be presenting at the Robert W. Baird Industrial Conference in Chicago, IL on Wednesday, November 12, 2008 at 1:55 p.m. CST. The audio will be simultaneously webcast on http://www.danaher.com.

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools and Components (http://www.danaher.com).


'/>"/>
SOURCE Danaher Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Danaher to Present at J.P. Morgan Healthcare Conference
2. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
3. The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
4. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
5. PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
6. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
7. VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations
8. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
9. China Yingxia to Present at Roth China Comes to Vegas Conference
10. WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11. Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... the deadline to participate in its previously announced ... consisting of shares of common stock and Series ... holders of listed warrants. As ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology:
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):